
- Stock: In Stock
- Model: 178557
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Beklometazon-Zdorovye spray nazat. doses. susp. 50mkg/dose fl. 180 doses
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
Beklometazon-Zdorovye - the nasal spray dosed, suspension for prevention and treatment of year-round and seasonal allergic rhinitis.
Structure
- active ingredient: beclometasone; 1 dose of medicine contains
- Dipropionas beclomethasone – 50 mkg;
- other components: microcrystalline cellulose and sodium of a karmeloz, glucose, a benzalkoniya chloride, phenylethyl alcohol, polysorbate 80, water purified.
Contraindication
Hypersensitivity to active ingredient or to any of excipients in the anamnesis. Tuberculosis, candidiasis, heavy attacks of bronchial asthma. Children's age.
Side reactions
from the immune system: reactions of hypersensitivity, including: often – rash, urticaria, an itch, an erythema; very seldom – a Quincke's disease, an eye, persons, lips and a throat, an asthma and/or a bronchospasm, anaphylactoid/anaphylactic reactions swelled.
from nervous system: often – feeling of unpleasant taste, a smell.
from organs of sight: very seldom – increase in intraocular pressure, glaucoma or a cataract; frequency is unknown – indistinct sight.
from a respiratory system: often – dryness and irritation of a nose and throat, nasal bleeding; cough, paradoxical bronchospasm, dispnoe; very seldom – isolated cases of perforation of a nasal partition.
At prolonged use of beclomethasone, especially in high doses, candidiasis, depression of function of bark of adrenal glands, osteoporosis, a growth inhibition at children is possible.
System influence of nasal corticosteroids can take place when using them in high doses during the long period.
Route of administration
should appoint Medicine byonly for intranasal application. Before application to shake up.
Adult: on 2 injections in each nasal course 2 times a day or on 1 injection in each nasal course 4 times a day.
Maximum daily dose should not exceed 8 injections (400 mkg).
toFor obtaining full therapeutic effect needs regular use of medicine. After the first several injections the maximum simplification is not reached.
not to usemore than 3 months without consultation of the doctor.
Feature of application
Infectious and inflammatory diseases of nasal ways and adnexal bosoms are not a specific contraindication for prescription of medicine, but in that case it is necessary to carry out the corresponding therapy.
Use during pregnancy or feeding by a breast
Pregnancy
is not enoughProofs of safety of use of medicine during pregnancy. Dipropionas beclomethasone use during pregnancy it is necessary to avoid, except for cases when, according to the doctor, the expected advantage of mother exceeds potential risk for a fruit.
feeding Period a breast
Prescribing of medicine to women during feeding by a breast perhaps only when, according to the doctor, the expected advantage for mother exceeds potential risk for the child.
Children
Medicine is not recommended to be applied to children.
Ability to influence speed of response at control of motor transport or other mechanisms
does not influence.
Overdose
Only harmful effect which can arise after inhalation of high doses for a short span is function oppression gipotalamo - a hypophysial and adrenal system. This state does not demand emergency aid. Use of medicine can be prolonged in the recommended doses. Function gipotalamo - a hypophysial and adrenal system will be restored in 1–2 days.
In this case should work withaccording to clinical indications or according to the recommendations of national poison control center (in the presence).
is not presentSpecific treatment of overdose of beclomethasone of Dipropionas.
if necessary should provide to the patient within case of overdose the corresponding supervision.
Interaction with other medicines and other types of interactionsBeclomethasone is less dependent
on metabolism of CYP3A, than some other corticosteroids, and in general interactions are improbable; however it is impossible to exclude a possibility of system effects at simultaneous use of strong CYP3A inhibitors (for example, a ritonavira, the kobitsistat). Therefore at simultaneous use of these medicines it is recommended to be careful and carry out the corresponding monitoring. Storage conditions
to Store
in original packing at a temperature not above 25 °C. you do not store
in the fridge.
to Storeout of children's reach.
Specifications
Characteristics | |
Active ingredients | Beclomethasone |
Amount of active ingredient | 0.05 mg / dose |
Applicant | Health |
Code of automatic telephone exchange | R01AD01 Beclomethasone |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | bottle |
Producer | TOB PHARMACEUTICAL COMPANY HEALTH |
Quantity in packing | 1 bottle |
Release form | nasal spray |
Route of administration | For inhalation |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Beclomethasone |